The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: A behavioral-electroencephalography study

Journal of Psychopharmacology

Volumn 27, Issue 7, 2013, Pages 600-608

  Reneerkens, O A H ^a   Sambeth, A ^a   Ramaekers, J G ^a   Steinbusch, H W M ^a   Blokland, A ^a   Prickaerts, J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cognition; executive functioning; human; learning; memory; phosphodiesterase

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; VARDENAFIL;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED HEADACHE; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MENTAL TASK; NEUROPSYCHOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SIDE EFFECT; SPATIAL MEMORY; VOLUNTEER; WEAKNESS;

COGNITION; EXECUTIVE FUNCTIONING; HUMAN; LEARNING; MEMORY; PHOSPHODIESTERASE;

ADULT; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IMIDAZOLES; MALE; MEMORY; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; REACTION TIME; SULFONES; TRIAZINES; YOUNG ADULT;

EID: 84878707501     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113477747     Document Type: Article

References (46)

1. Akhondzadeh S, Ghayyoumi R, Rezaei F, et al. Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: A double-blind randomized placebo-controlled trial. Psychopharmacology (Berl). 2011 ; 213: 809-815
2. Baratti CM, Boccia MM. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol. 1999 ; 10: 731-737
3. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev. 2006 ; 58: 488-520
4. Bond A, Lader M. The use of visual analogue scales in rating subjective feelings. Br J Med Psychol. 1974 ; 80: 1-16
5. Bossong MG, Jager G, van Hell HH, et al. Effects of Delta9- tetrahydrocannabinol administration on human encoding and recall memory function: A pharmacological FMRI study. J Cogn Neurosci. 2012 ; 24: 588-599
6. Cacioppo JT, Tassinary LG, Berntson GG Handbook of Psychophysiology. Cambridge: Cambridge University Press ; 2000
7. Curran HV, Pooviboonsuk P, Dalton JA, et al. Differentiating the effects of centrally acting drugs on arousal and memory: An event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl). 1998 ; 135: 27-36
8. Dassanayake TL, Michie PT, Jones A, et al. Cognitive impairment in patients clinically recovered from central nervous system depressant drug overdose. J Clin Pharmacol. 2012 ; 32: 503-510
9. Devan BD, Pistell PJ, Daffin LW, et al. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor N(omega)-nitro-L-arginine methyl ester. Eur J Pharmacol. 2007 ; 563: 134-140
10. Domek-Lopacinska K, Strosznajder JB. The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. Brain Res. 2008 ; 1216: 68-77
11. EMEA (2008) European Public Assesment Report; Revision 6. www.emea.europa.eu.
12. Federmeier KD and Laszlo S (2009) Time for meaning: Electrophysiology provides insights into the dynamics of representation and processing in semantic memory. In: Ross BH (ed) Psychology of Learning and Motivation. Burlington: Academic Press, pp.1-44.
13. Gazzaniga MS, Ivry RB, Mangun GR Cognitive Neuroscience: The Biology of the Mind. New York: WW Norton & Company, Inc ; 2002 :
14. Goff DC, Cather C, Freudenreich O, et al. A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology (Berl). 2009 ; 202: 411-417
15. Grass H, Klotz T, Fathian-Sabet B, et al. Sildenafil (Viagra): Is there an influence on psychological performance?. Int Urol Nephrol. 2001 ; 32: 409-412
16. Jasper H. The ten-twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol. 1958 ; 10: 371-375
17. Kessels RP, Postma A, de Haan EH. Object Relocation: A program for setting up, running, and analyzing experiments on memory for object locations. Behav Res Methods Instrum Comput. 1999 ; 31: 423-428
18. Lakics V, Karran EH, Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010 ; 59: 367-374
19. Langtry HD, Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs. 1999 ; 57: 967-989
20. Lezak MD Neuropsychological Assessment. Oxford: Oxford University Press ; 1995
21. Linssen AM, Riedel WJ, Sambeth A. Effects of tyrosine/ henylalanine depletion on electrophysiological correlates of memory in healthy volunteers. J Psychopharmacol. 2011 ; 25: 230-238
22. Loughney K, Hill TR, Florio VA, et al. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′- cyclic nucleotide phosphodiesterase. Gene. 1998 ; 216: 139-147
23. Luck SJ An Introduction to the Event-Related Potential Technique. Cambridge, MA: MIT Press ; 2005
24. McNair DM, Lorr M, Droppleman LF Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service ; 1971 :
25. Patil CS, Jain NK, Singh VP, et al. Differential effect of the PDE5 inhibitors, sildenafil and zaprinast, in aging- and lippolysaccharide-induced cognitive dysfunction in mice. Drug Dev Res. 2004 ; 63: 66-75
26. Prickaerts J, Steinbusch HW, Smits JF, et al. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: Effects of 7-nitroindazole and zaprinast. Eur J Pharmacol. 1997 ; 337: 125-136
27. Prickaerts J, van Staveren WC, Sik A, et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience. 2002 ; 113: 351-361
28. Puzzo D, Staniszewski A, Deng SX, et al. Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J Neurosci. 2009 ; 29: 8075-8086
29. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008 ; 22: 659-661
30. Reneerkens OA, Rutten K, Akkerman S, et al. Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: Indications for central and peripheral mechanisms. Neurobiol Learn Mem. 2012 ; 97: 370-379
31. Reneerkens OA, Rutten K, Steinbusch HW, et al. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl). 2009 ; 202: 419-443
32. Reneerkens OA, Sambeth A, Van Duinen MA, et al. The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans. Psychopharmacology (Berl). 2013 ; 225: 303-312
33. Reyes-Irisarri E, Markerink-Van Ittersum M, Mengod G, et al. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains. Eur J Neurosci. 2007 ; 25: 3332-3338
34. Riedel WJ, Klaassen T, Deutz NE, et al. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl). 1999 ; 141: 362-369
35. Rodefer JS, Saland SK, Eckrich SJ. Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats. Neuropharmacology. 2012 ; 62: 1182-1190
36. Rutten K, Basile JL, Prickaerts J, et al. Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology (Berl). 2008 ; 196: 643-648
37. Rutten K, Prickaerts J, Hendrix M, et al. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol. 2007 ; 558: 107-112
38. Rutten K, Vente JD, Sik A, et al. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav Brain Res. 2005 ; 164: 11-16
39. Sambeth A, Riedel WJ, Tillie DE, et al. Memory impairments in humans after acute tryptophan depletion using a novel gelatin-based protein drink. J Psychopharmacol. 2009 ; 23: 56-64
40. Schmitt JA, Jorissen BL, Dye L, et al. Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein. J Psychopharmacol. 2005 ; 19: 375-384
41. Schultheiss D, Muller SV, Nager W, et al. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol. 2001 ; 19: 46-50
42. Setter SM, Iltz JL, Fincham JE, et al. Phosphodiesterase 5 inhibitors for erectile dysfunction. Ann Pharmacother. 2005 ; 39: 1286-1295
43. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci. 1982 ; 298: 199-209
44. Shim YS, Pae CU, Kim SW, et al. Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: A pilot study. Int J Impot Res. 2011 ; 23: 109-114
45. Van Donkelaar EL, Rutten K, Blokland A, et al. Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion. Eur J Pharmacol. 2008 ; 600: 98-104
46. Van Strien JW, Verkoeijen PP, Van der Meer N, et al. Electrophysiological correlates of word repetition spacing: ERP and induced band power old/new effects with massed and spaced repetitions. Int J Psychophysiol. 2007 ; 66: 205-214